We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LAES:NASDAQSEALSQ Corp Analysis

Data as of 2026-04-14 - not real-time

$2.14

Latest Price

8/10Risk

Risk Level: High

Executive Summary

SEALSQ Corp (LAES) trades at $2.14, hovering just above its calculated support of $1.99 and well below its 20‑day SMA of $2.60, 50‑day SMA of $3.43 and 200‑day SMA of $4.01, indicating a strong bearish price bias. The RSI of 27.4 suggests the stock is oversold, while the MACD histogram of –0.016 and a bearish MACD signal reinforce downward momentum. Volatility is extreme at ~89% over the past 30 days and beta exceeds 2.8, exposing the equity to amplified market swings. Despite these technical headwinds, the company reported a **200% YoY jump in Q1 revenue to $4.1 M** and announced a strategic LOI to acquire Miraex SA, a photonics‑based quantum interconnect firm, signaling potential top‑line acceleration. Cash on hand ($427.7 M) dwarfs total debt ($8.0 M), yielding a low debt‑to‑equity ratio and a price‑to‑book under 1.0, which could make the stock appear undervalued relative to its balance sheet. However, operating margins are deeply negative (‑138%) and free cash flow remains negative, underscoring ongoing profitability challenges. The confluence of a distressed technical outlook, outsized volatility, and a nascent growth narrative suggests a speculative play that may reward short‑term contrarian traders but remains high‑risk for longer horizons.
Given the extreme market greed index (87.3) and a bullish analyst consensus (strong buy), investors must weigh the upside potential from the quantum‑semiconductor roadmap against the material risk of continued losses, high beta exposure, and a bearish price trend. The stock’s upside/downside profile of ~180% upside versus ~30% downside reflects a wide valuation spread, but realistic expectations should be tempered by the need for sustained revenue growth and margin improvement before any meaningful re‑rating can occur.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Oversold RSI but bearish MACD and price below all moving averages
  • Support level near current price limiting downside
  • High volatility and beta increasing price swing risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of >200% YoY and acquisition of Miraex expanding product addressable market
  • Strong cash position relative to debt providing runway for R&D
  • Strategic plan targeting silicon‑based quantum computing could unlock new revenue streams

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Fundamental profitability remains negative with large operating losses
  • Sector cyclicality and rapid technology evolution create execution risk
  • Potential valuation upside if margins improve and quantum roadmap materializes

Key Metrics & Analysis

Financial Health

Revenue Growth118.20%
Profit Margin-187.34%
P/E Ratio-14.3
ROE-12.71%
ROA-8.27%
Debt/Equity1.73
P/B Ratio0.9
Op. Cash Flow$-31257000
Free Cash Flow$-10687875
Industry P/E34.6

Technical Analysis

TrendBearish
RSI27.4
Support$1.99
Resistance$3.58
MA 20$2.60
MA 50$3.43
MA 200$4.01
MACDBearish
VolumeIncreasing
Fear & Greed Index87.29

Valuation

Target Price$6.00
Upside/Downside180.37%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.82
Volatility88.93%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.